secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARLSMED, INC. (CARL)
CIK:        0001794546
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001794546-26-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carlsmed Q1 revenue $16.1M (+58% YoY); raises FY2026 guidance to $72-77M
------------------------------------------------------------------------

- Revenue $16.1M, up 58% YoY from $10.2M; gross margin 77.1% vs 74.9%.
- Net loss ($8.7M) vs ($5.7M); adjusted EBITDA ($7.5M) vs ($5.5M).
- FY2026 revenue guidance raised to $72-$77M from prior $70-$75M.
- Study in Global Spine Journal shows 74% reduction in reoperations with aprevo implants.
- First procedures completed with corra cervical plating system and aprevo bi-lateral posterior in Feb.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1794546/000179454626000010/0001794546-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1794546/000179454626000010/carl-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001794546-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer